5:04 PM
Nov 12, 2013
 |  BC Extra  |  Financial News

Liquidia spins out ophthalmic newco Envisia

Liquidia Technologies Inc. (Research Triangle Park, N.C.) spun out its ophthalmology programs into Envisia Therapeutics Inc. (Research Triangle Park, N.C.), which secured $25 million in a series A round from Canaan Partners; New Enterprise Associates; Pappas Ventures; Morningside Technology...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >